Cover Image

A first‐in‐human, randomized study of the safety, pharmacokinetics and pharmacodynamics of povetacicept, an enhanced dual BAFF/APRIL antagonist, in healthy adults

Abstract Therapeutic agents targeting the tumor necrosis factor (TNF) superfamily cytokines B‐cell activating factor (BAFF, BLyS) and/or A PRoliferation Inducing Ligand (APRIL) have demonstrated clinical effectiveness in multiple autoimmune diseases, such as systemic lupus erythematosus, lupus nephr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rupert Davies (Author), Stanford L. Peng (Author), Jason Lickliter (Author), Kristi McLendon (Author), Amanda Enstrom (Author), Allison G. Chunyk (Author), Lori Blanchfield (Author), NingXin Wang (Author), Tiffany Blair (Author), Heather M. Thomas (Author), Alina Smith (Author), Stacey R. Dillon (Author)
Format:	Book
Published:	Wiley, 2024-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

BAFF, APRIL, and their receptors: physiological role and involvement in the pathogenesis of chronic lymphocytic leukemia
by: Katarzyna Schab, et al.
Published: (2018)

BAFF, APRIL, and their receptors: physiological role and involvement in the pathogenesis of chronic lymphocytic leukemia
by: Katarzyna Schab, et al.
Published: (2018)

BAFF/APRIL pathway in Sjögren syndrome and systemic lupus erythematosus: relationship with chronic inflammation and disease activity
by: A. Rigon, et al.
Published: (2011)

Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents
by: Lenert A, et al.
Published: (2015)

B cell phenotype and serum levels of interferons, BAFF, and APRIL in multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C)
by: Adam Klocperk, et al.
Published: (2023)

First‐in‐human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN‐101, a dual CD28/ICOS antagonist, in healthy adult subjects
by: Jing Yang, et al.
Published: (2021)

CD40- and CD95-specific antibody single chain-Baff fusion proteins display BaffR-, TACI- and BCMA-restricted agonism
by: Johannes Nelke, et al.
Published: (2020)

Associations of BAFF rs2893321 polymorphisms with myasthenia gravis susceptibility
by: Hui Deng, et al.
Published: (2019)

Monoclonal Antibodies as an Antibacterial Approach Against Bacterial Pathogens
by: Daniel V. Zurawski, et al.
Published: (2020)

The levels of BAFF and regulatory B cells and their association with systemic lupus erythematosus
by: Zhi-xuan GUO, et al.
Published: (2020)

Structured Annual Faculty Review Program Accelerates Professional Development and Promotion
by: Stanley J. Robboy MD, et al.
Published: (2017)

Increased B cell-activating factor (BAFF) level in the sputum of children with asthma
by: Hye Mi Jee, et al.
Published: (2010)

BAFF mediates splenic B cell response and antibody production in experimental Chagas disease.
by: Daniela A Bermejo, et al.
Published: (2010)

The Effect of BAFF Inhibition on Autoreactive B-Cell Selection in Murine Systemic Lupus Erythematosus
by: Alexis Boneparth, et al.
Published: (2016)

A phase 1, randomized, double-blind, placebo-controlled, dose escalation study to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of SHR-1905, a long-acting anti-thymic stromal lymphopoietin antibody, in healthy subjects
by: Yue Fei, et al.
Published: (2024)

B cell activation factor (BAFF) induces inflammation in the human fallopian tube leading to tubal pregnancy
by: Jianying Xu, et al.
Published: (2019)

Abnormal expression of BAFF and its receptors in peripheral blood and skin lesions from systemic lupus erythematosus patients
by: Yongjian Chen, et al.
Published: (2020)

Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson's disease
by: Colleen S. Stein, et al.
Published: (2022)

Metabolomic Profiling of Lungs from Mice Reveals the Variability of Metabolites in Pneumocystis Infection and the Metabolic Abnormalities in BAFF-R-Deficient Mice
by: Rong HM, et al.
Published: (2023)

Therapeutic potential of hydroxychloroquine on serum B-cell activating factor belonging to the tumor necrosis factor family (BAFF) in rheumatoid arthritis patients
by: Amina A. Mahdy, et al.
Published: (2014)

Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses.
by: Joseph R Plummer, et al.
Published: (2019)

Pharmacodynamics of the Glutamate Receptor Antagonists in the Rat Barrel Cortex
by: Daria Vinokurova, et al.
Published: (2018)

Understanding the Hysteresis Loop Conundrum in Pharmacokinetic / Pharmacodynamic Relationships
by: Christopher Louizos, et al.
Published: (2014)

Response to Criticism of "Fine Particulate Matter and Total Mortality in Cancer Prevention Study Cohort Reanalysis"
by: James E. Enstrom
Published: (2018)

Fine Particulate Matter and Total Mortality in Cancer Prevention Study Cohort Reanalysis
by: James E. Enstrom
Published: (2017)

The Galaxy, April, 1877 Vol. XXIII.—April, 1877.—No. 4.
by: Various

Roland Hauspie (April 8, 1948-April 25, 2017)
by: Mathieu Roelants, et al.
Published: (2017)

April Hopes
by: Howells, William Dean, 1837-1920

The Enchanted April
by: Von Arnim, Elizabeth, 1866-1941

The first of April;
by: Combe, William, 1742-1823

Black April
by: Peterkin, Julia, 1880-1961

Second April
by: Millay, Edna St. Vincent, 1892-1950

Iron scavenging and suppression of collagen cross-linking underlie antifibrotic effects of carnosine in the heart with obesity
by: Islam A. Berdaweel, et al.
Published: (2024)

An overview of pharmacodynamic
by: Mohammed Saji Salahudeen, et al.
Published: (2017)

Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?
by: Stephen T. Abedon
Published: (2019)

CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents
by: Feng Zhang, et al.
Published: (2017)

Pre-Clinical Pharmacokinetic and Pharmacodynamic Characterization of Selected Chiral Flavonoids: Pinocembrin and Pinostrobin
by: Casey L. Sayre, et al.
Published: (2015)

Appletons' Popular Science Monthly, April 1899 Volume LIV, No. 6, April 1899
by: Various; Youmans, William Jay, 1838-1901 [Editor]

Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of the P2Y12 receptor antagonist selatogrel
by: Uta Schilling, et al.
Published: (2022)

Establishment and Validation of a Rabbit Model for In Vivo Pharmacodynamic Screening of Tachykinin NK2 Antagonists
by: Takahiro Tanaka, et al.
Published: (2012)